In order to sustain fast growth, cancer cells need to take up nutrients at a faster rate than healthy cells. The human glutamine transporter ASCT2 allows the amino acid glutamine to enter cells and is upregulated in many types of cancer cells, which need more glutamine. It is a potential target for new anti-cancer drugs. Researchers have now elucidated a structure of the human ASCT2 that provides unprecedented insight in the workings of this protein.
from Latest Science News -- ScienceDaily https://ift.tt/2Yx7Ao3
via IFTTT
Wednesday, July 31, 2019
Closing the door: Breaking new ground related to a potential anticancer drug target
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment